GB201802679D0 - Dosage regime - Google Patents

Dosage regime

Info

Publication number
GB201802679D0
GB201802679D0 GBGB1802679.9A GB201802679A GB201802679D0 GB 201802679 D0 GB201802679 D0 GB 201802679D0 GB 201802679 A GB201802679 A GB 201802679A GB 201802679 D0 GB201802679 D0 GB 201802679D0
Authority
GB
United Kingdom
Prior art keywords
dosage regime
regime
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1802679.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1802679.9A priority Critical patent/GB201802679D0/en
Publication of GB201802679D0 publication Critical patent/GB201802679D0/en
Priority to AU2018285562A priority patent/AU2018285562B2/en
Priority to UAA202100090A priority patent/UA127900C2/en
Priority to MX2019015042A priority patent/MX2019015042A/en
Priority to CA3064804A priority patent/CA3064804A1/en
Priority to US16/622,649 priority patent/US11318211B2/en
Priority to PCT/EP2018/065873 priority patent/WO2018229222A1/en
Priority to KR1020197037482A priority patent/KR102442736B1/en
Priority to EP18732041.1A priority patent/EP3638373A1/en
Priority to JP2019569479A priority patent/JP7145891B2/en
Priority to BR112019026564-3A priority patent/BR112019026564A2/en
Priority to US17/699,065 priority patent/US11938192B2/en
Priority to JP2022148738A priority patent/JP2022191244A/en
Priority to US17/938,193 priority patent/US20230106885A1/en
Ceased legal-status Critical Current

Links

GBGB1802679.9A 2017-06-14 2018-02-20 Dosage regime Ceased GB201802679D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1802679.9A GB201802679D0 (en) 2018-02-20 2018-02-20 Dosage regime
BR112019026564-3A BR112019026564A2 (en) 2017-06-14 2018-06-14 dosing regimens for administration of an anti-cd19 adc
PCT/EP2018/065873 WO2018229222A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd19 adc
EP18732041.1A EP3638373A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd19 adc
MX2019015042A MX2019015042A (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd19 adc.
CA3064804A CA3064804A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd19 adc
US16/622,649 US11318211B2 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-CD19 ADC
AU2018285562A AU2018285562B2 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-CD19 ADC
KR1020197037482A KR102442736B1 (en) 2017-06-14 2018-06-14 Dosage regime for administration of anti-CD19 ADCs
UAA202100090A UA127900C2 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd19 adc
JP2019569479A JP7145891B2 (en) 2017-06-14 2018-06-14 Dosing Regimens for Administering Anti-CD19 ADCs
US17/699,065 US11938192B2 (en) 2017-06-14 2022-03-18 Dosage regimes for the administration of an anti-CD19 ADC
JP2022148738A JP2022191244A (en) 2017-06-14 2022-09-20 Dosage regimes for administration of anti-cd19 adc
US17/938,193 US20230106885A1 (en) 2017-06-14 2022-10-05 Dosage regime

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1802679.9A GB201802679D0 (en) 2018-02-20 2018-02-20 Dosage regime

Publications (1)

Publication Number Publication Date
GB201802679D0 true GB201802679D0 (en) 2018-04-04

Family

ID=61783630

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1802679.9A Ceased GB201802679D0 (en) 2017-06-14 2018-02-20 Dosage regime

Country Status (1)

Country Link
GB (1) GB201802679D0 (en)

Similar Documents

Publication Publication Date Title
IL276232A (en) Pharmaceutical compounds
GB2569961B (en) Pharmaceutical
GB2572126B (en) Pharmaceutical
GB2572125B (en) Pharmaceutical
GB201810245D0 (en) Pharmaceutical compounds
GB201713653D0 (en) Dosage regimen
IL275708A (en) G1t38 superior dosage regimes
IL283900A (en) Pharmaceutical combinations
GB201810239D0 (en) Pharmaceutical compounds
GB201819961D0 (en) Pharmaceutical compounds
IL277334A (en) Pharmaceutical combinations
GB201819960D0 (en) Pharmaceutical compounds
IL279334A (en) Pharmaceutical combinations
GB201801562D0 (en) Pharmaceutical compounds
GB201800378D0 (en) Pharmaceutical compounds
IL269169A (en) Novel dosage form
GB201816369D0 (en) Pharmaceutical compounds
GB201607548D0 (en) Solid dosage form
GB201812049D0 (en) Pesticidal dosage form
GB201808473D0 (en) Dosage regime
GB201808507D0 (en) Dosage Regime
GB201808101D0 (en) Dosage regime
GB201803298D0 (en) Dosage regime
GB201802679D0 (en) Dosage regime
GB201720544D0 (en) Dosage regime

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)